C91.60
Prolymphocytic leukemia of T-cell type not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Prolymphocytic leukemia of T-cell type with failed remission
- Prolymphocytic leukemia of T-cell type NOS
Medical Intelligence & Overview
Prolymphocytic leukemia of T-cell type is a rare and aggressive form of blood cancer characterized by the abnormal growth of T-lymphocytes, a type of white blood cell. When this condition does not respond to treatment and fails to enter remission, it signifies an advanced stage, demanding ongoing medical attention. This article provides an easy-to-understand overview of this disease, including its causes, symptoms, diagnosis, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting T-cell development and regulation A history of other blood disorders or immune system issues Exposure to certain environmental toxins or radiation Rare familial genetic predispositions
Key Symptoms: Unexplained weight loss Fever and night sweats Swelling or painless lumps in the lymph nodes Fatigue and weakness Frequent infections due to immune system impairment Enlarged spleen or liver Easy bruising or bleeding
Diagnostic & Treatment
Diagnosis Path: Blood tests: To check for abnormal lymphocyte levels and morphology Bone marrow biopsy: To examine marrow cells and confirm infiltration Flow cytometry: To analyze cell surface markers and classify T-cell types Imaging studies: Such as CT scans to assess lymph nodes and organ involvement Molecular tests: To identify genetic abnormalities linked to the disease
Treatment Protocols: Chemotherapy: Using drugs to destroy cancerous cells Targeted therapy: Medications designed to target specific genetic mutations Immunotherapy: Boosting the immune system's ability to fight cancer Stem cell transplantation: Replacing diseased marrow with healthy stem cells, typically considered in suitable candidates Supportive care: Managing symptoms and preventing infections
Clinical Advice & FAQs
Billing Guidance
Is C91.60 a billable ICD-10 code?
Yes, C91.60 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C91.60?
Clinical documentation must specify the nature of Prolymphocytic leukemia of T-cell type not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference